What the research found

A systematic review of older adults with sarcopenia found that pairing strength training with whey protein supplementation produced measurable gains in lean muscle mass and grip strength. Participants also showed improvements in functional tests like sit-to-stand and walking speed—practical indicators of whether someone can maintain independence in daily life. Notably, adding HMB (a leucine metabolite) to this combination didn't appear to improve outcomes beyond whey protein alone.

A separate analysis examined myostatin, a regulatory protein that acts as a natural brake on muscle growth. The review notes that blocking myostatin can theoretically increase protein synthesis and muscle regeneration, and that variations in myostatin genetics help explain why individuals differ in their capacity to build muscle or excel at endurance versus strength-based activities.

A third piece in Lancet Healthy Longevity broadens the lens beyond physical metrics, arguing that durable aging depends on preserving multiple domains: physical capability, cognitive function, mood regulation, sensory acuity, and social engagement. The authors frame this as "intrinsic capacity"—a combination of what your body can do and the environmental context in which you live.

Why it matters for you

If you're tracking muscle mass and strength biomarkers, the whey + resistance training finding is straightforward: these are two of the most evidence-backed inputs for fighting age-related muscle loss. This doesn't require exotic compounds—it's a reminder that consistency with basic resistance work and adequate protein intake remain foundational, especially as you age. Most MyKine users already log resistance training; pairing it with tracked protein targets (whey-based or otherwise) appears to meaningfully move the needle on functional outcomes, not just aesthetics.

The myostatin insight is more speculative but worth noting. If you're interested in genetic testing or biomarker panels that profile muscle-related pathways, myostatin status could eventually inform whether your protocol should prioritize different stimulus types. For now, it's a reminder that genetics set a range—two people following identical training and nutrition won't necessarily see identical results, and that's normal biology, not protocol failure.

The third point is a useful reality check for MyKine users who quantify everything. Tracking grip strength, lean mass, or VO₂ max is valuable, but these are levers, not the whole picture. Sleep, mood, cognitive reserve, and meaningful relationships are harder to log but arguably as important to long-term healthspan. If you're optimizing peptides, TRT, or supplements while neglecting sleep consistency or social connection, you're leaving longevity potential on the table.

Caveats

• The whey + strength training finding comes from a systematic review (summary of existing studies); individual trial sizes and quality not specified in the source
• Myostatin research remains largely mechanistic and animal-model–based; human applications for blocking myostatin are not yet established
• The broader "intrinsic capacity" framework is conceptual and policy-oriented; no new outcome data provided
• Environmental and social factors are acknowledged as influential but difficult to quantify or control in traditional biomarker-tracking apps